Shandong Wohua Pharmaceutical Co Ltd (002107) — Working Capital to Net Assets Ratio

Latest as of June 2026: 45.8%

Shandong Wohua Pharmaceutical Co Ltd (002107) has a Working Capital to Net Assets ratio of 45.8% as of June 2026. Working capital of CN¥322.72 Million (current assets of CN¥559.80 Million minus current liabilities of CN¥237.08 Million) is measured against net assets of CN¥704.13 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shandong Wohua Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

45.8%
Working Capital / Net Assets

Working Capital

CN¥322.72 Million
CNY

Current Assets

CN¥559.80 Million
CNY

Current Liabilities

CN¥237.08 Million
CNY

Shandong Wohua Pharmaceutical Co Ltd Working Capital to Net Assets (2003–2025)

This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of June 2026, the ratio stands at 45.8%, reflecting working capital of CN¥322.72 Million against net assets of CN¥704.13 Million CNY. For the complete balance sheet picture, see 002107 current and non-current assets.

Annual Working Capital to Net Assets for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Shandong Wohua Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 44.5% CN¥326.04 Million CN¥732.64 Million CN¥566.77 Million CN¥240.73 Million ▲ +2.9 pp
2024 41.6% CN¥300.83 Million CN¥722.93 Million CN¥543.12 Million CN¥242.29 Million ▼ -4.6 pp
2023 46.2% CN¥385.01 Million CN¥833.48 Million CN¥673.00 Million CN¥287.99 Million ▲ +6.2 pp
2022 40.0% CN¥315.76 Million CN¥789.79 Million CN¥599.21 Million CN¥283.44 Million ▼ -4.9 pp
2021 44.9% CN¥416.82 Million CN¥929.26 Million CN¥620.57 Million CN¥203.74 Million ▲ +4.5 pp
2020 40.4% CN¥370.52 Million CN¥918.01 Million CN¥794.17 Million CN¥423.64 Million ▼ -12.1 pp
2019 52.4% CN¥406.47 Million CN¥775.15 Million CN¥619.21 Million CN¥212.74 Million ▲ +2.3 pp
2018 50.1% CN¥348.62 Million CN¥695.78 Million CN¥561.59 Million CN¥212.97 Million ▼ -3.1 pp
2017 53.2% CN¥348.77 Million CN¥655.78 Million CN¥538.62 Million CN¥189.85 Million ▲ +3.5 pp
2016 49.7% CN¥284.75 Million CN¥572.64 Million CN¥378.91 Million CN¥94.16 Million ▲ +1.4 pp
2015 48.3% CN¥264.32 Million CN¥547.26 Million CN¥346.28 Million CN¥81.96 Million ▼ -15.4 pp
2014 63.7% CN¥402.51 Million CN¥631.74 Million CN¥435.30 Million CN¥32.79 Million ▲ +3.6 pp
2013 60.1% CN¥363.80 Million CN¥605.04 Million CN¥400.16 Million CN¥36.37 Million ▲ +1.8 pp
2012 58.3% CN¥346.57 Million CN¥594.41 Million CN¥386.86 Million CN¥40.28 Million ▼ -5.2 pp
2011 63.5% CN¥372.43 Million CN¥586.07 Million CN¥408.71 Million CN¥36.28 Million ▼ -0.4 pp
2010 63.9% CN¥377.62 Million CN¥590.64 Million CN¥413.12 Million CN¥35.49 Million ▼ -6.5 pp
2009 70.4% CN¥484.69 Million CN¥688.45 Million CN¥560.10 Million CN¥75.41 Million ▲ +6.6 pp
2008 63.8% CN¥406.94 Million CN¥637.88 Million CN¥479.49 Million CN¥72.54 Million ▲ +10.2 pp
2007 53.6% CN¥183.47 Million CN¥342.22 Million CN¥271.07 Million CN¥87.60 Million ▲ +33.3 pp
2006 20.3% CN¥28.90 Million CN¥142.57 Million CN¥120.94 Million CN¥92.04 Million ▼ -34.5 pp
2005 54.8% CN¥60.88 Million CN¥111.06 Million CN¥142.66 Million CN¥81.78 Million ▲ +18.2 pp
2004 36.6% CN¥30.27 Million CN¥82.62 Million CN¥98.86 Million CN¥68.59 Million ▲ +40.8 pp
2003 -4.2% CN¥-2.17 Million CN¥51.69 Million CN¥80.40 Million CN¥82.57 Million —
pp = percentage points